دورية أكاديمية
Risk of inpatient epistaxis admission related to oral anticoagulation medication use
العنوان: | Risk of inpatient epistaxis admission related to oral anticoagulation medication use |
---|---|
المؤلفون: | Margaret B. Mitchell, Alan D. Workman, Richard Lu, Neil Bhattacharyya |
المصدر: | Laryngoscope Investigative Otolaryngology, Vol 8, Iss 4, Pp 824-826 (2023) |
بيانات النشر: | Wiley, 2023. |
سنة النشر: | 2023 |
المجموعة: | LCC:Otorhinolaryngology LCC:Surgery |
مصطلحات موضوعية: | admission, anticoagulation, aspirin, clopidogrel, DOAC, epistaxis, Otorhinolaryngology, RF1-547, Surgery, RD1-811 |
الوصف: | Abstract We utilized a case control study to determine if novel oral anticoagulants were associated with a higher risk of inpatient epistaxis admission. Adult patients admitted with a principal diagnosis of epistaxis in 2019–2021 were identified as well as a control group of patients matched 1:1 for age, sex, race, and medical comorbidities. For both cohorts, the presence or absence of an oral anticoagulant, classified as vitamin K inhibitors, direct oral anticoagulants (DOAC) or platelet inhibitors, was identified. 158 adult unique inpatient admissions with a principal diagnosis of epistaxis were identified. Vitamin K inhibition was present in 5.7% of cases versus 0.6% of controls (p = 0.02; OR 9.48, range 1.19‐75.77), DOACs in 4.4% of cases versus 5.1% of controls (p = 1.0) and platelet inhibitors in 2.5% of cases versus 3.8% of controls (p = 0.75). We concluded vitamin K inhibitors, compared to DOACs and platelet inhibitors, may be associated with higher likelihood of epistaxis admission. |
نوع الوثيقة: | article |
وصف الملف: | electronic resource |
اللغة: | English |
تدمد: | 2378-8038 |
Relation: | https://doaj.org/toc/2378-8038 |
DOI: | 10.1002/lio2.1111 |
URL الوصول: | https://doaj.org/article/fd8f6bb9561e4f7fb37dbd8585ac2cbf |
رقم الأكسشن: | edsdoj.fd8f6bb9561e4f7fb37dbd8585ac2cbf |
قاعدة البيانات: | Directory of Open Access Journals |
تدمد: | 23788038 |
---|---|
DOI: | 10.1002/lio2.1111 |